News Article
Disruption has arrived for ‘big pharma’
21 December 2017
Candesic’s Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech space.
![](https://candesic.com/wp-content/uploads/2024/04/Copy-of-Copy-of-Website-publications-photos-RESIZING-54.png)
Candesic’s Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech space.